Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Relay Therapeutics (RLAY) Non Operating Income: 2019-2024

Historic Non Operating Income for Relay Therapeutics (RLAY) over the last 6 years, with Dec 2024 value amounting to $34.8 million.

  • Relay Therapeutics' Non Operating Income fell 24.47% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.5 million, marking a year-over-year decrease of 14.48%. This contributed to the annual value of $34.8 million for FY2024, which is 12.03% up from last year.
  • According to the latest figures from FY2024, Relay Therapeutics' Non Operating Income is $34.8 million, which was up 12.03% from $31.0 million recorded in FY2023.
  • In the past 5 years, Relay Therapeutics' Non Operating Income ranged from a high of $34.8 million in FY2024 and a low of $826,000 during FY2021.
  • Its 3-year average for Non Operating Income is $24.9 million, with a median of $31.0 million in 2023.
  • Its Non Operating Income has fluctuated over the past 5 years, first crashed by 75.59% in 2021, then skyrocketed by 961.26% in 2022.
  • Yearly analysis of 5 years shows Relay Therapeutics' Non Operating Income stood at $3.4 million in 2020, then tumbled by 75.59% to $826,000 in 2021, then surged by 961.26% to $8.8 million in 2022, then soared by 253.95% to $31.0 million in 2023, then increased by 12.03% to $34.8 million in 2024.